Trump’s Covid Treatments Suggest a Serious Condition
NY Times
OCTOBER 3, 2020
Outside experts pointed to the therapies as signs that the president’s health may not be as good as his doctors said. His age, weight and gender put him at high risk.
NY Times
OCTOBER 3, 2020
Outside experts pointed to the therapies as signs that the president’s health may not be as good as his doctors said. His age, weight and gender put him at high risk.
Scienmag
OCTOBER 3, 2020
Researchers used National Cancer Database data to find minority-serving hospitals offer a strong level of evidence-based care when accredited by the Commission on Cancer CHICAGO: Among accredited U.S. cancer centers, hospitals serving primarily minority patients are as likely as other hospitals to offer the standard of surgical care for early-stage breast cancer, according to results […].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Times
OCTOBER 3, 2020
No patients were affected, but the incident was another reminder of the risks in the increasingly common assaults on computer networks.
Scienmag
OCTOBER 3, 2020
Guidelines have successfully reduced opioid prescriptions, but a small group of surgical patients may still need more pain control than previously anticipated CHICAGO: To address the opioid epidemic, surgeons have embraced guidelines to reduce the number of opioid pills they prescribe to patients after surgery, and the efforts have helped to significantly reduce the number […].
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Patent Watch
OCTOBER 3, 2020
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…. The post New patent expiration for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
OCTOBER 3, 2020
Military-civilian partnerships promote readiness and optimal patient care among military trauma teams, not just individuals Credit: American College of Surgeons CHICAGO: Military surgical teams face unique demands on and off the battlefield. Combat trauma represents 0.5 percent of the 1 million annual military health system hospital admissions, presenting a challenge for military surgical teams to […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
OCTOBER 3, 2020
Participants retained knowledge from the course and demonstrated a willingness to help in a bleeding emergency according to two new studies Credit: American College of Surgeons CHICAGO: The STOP THE BLEED® course teaches a skill with lifesaving potential that is easy to learn and globally relevant. Two studies presented at the American College of Surgeons […].
Drug Patent Watch
OCTOBER 3, 2020
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…. The post New patent expiration for Astrazeneca Ab drug BYDUREON BCISE appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
OCTOBER 3, 2020
Using geographic information systems, researchers find disproportionate public transportation burden on minority neighborhoods. CHICAGO: Transportation barriers, such as personal access to a vehicle or public transportation, disproportionally affect minority communities, according to results of a new study presented at the virtual American College of Surgeons (ACS) Clinical Congress 2020.
Drug Patent Watch
OCTOBER 3, 2020
Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are ten…. The post New patent expiration for Astrazeneca Ab drug QTERNMET XR appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
OCTOBER 3, 2020
Machine learning streamlines massive amounts of data to support provider decision-making at the point of care for motor vehicle crash victims and patients awaiting a liver transplant Credit: American College of Surgeons CHICAGO: New applications of artificial intelligence (AI) in health care settings have shown early success in improving survival and outcomes in traffic accident […].
Drug Patent Watch
OCTOBER 3, 2020
Annual Drug Patent Expirations for XIGDUO+XR Xigduo Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are eight…. The post New patent expiration for Astrazeneca Ab drug XIGDUO XR appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
OCTOBER 3, 2020
Surgeons find that shifting to virtual visits could be a way to improve patient-centered care, satisfy busy patients Credit: American College of Surgeons CHICAGO: Surgical patients who participate in virtual follow-up visits after their operations spend a similar amount of time with surgical team members as those who meet face-to-face. Moreover, these patients benefit by […].
Drug Patent Watch
OCTOBER 3, 2020
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three suppliers. There are eighteen patents…. The post New patent expiration for Astrazeneca Ab drug FARXIGA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
OCTOBER 3, 2020
Sociologists use twice-a-day texts to examine whether spirituality’s link with satisfaction is stable or momentary Credit: Baylor University Using smartphone check-ins twice a day for two weeks, sociologists in a national study have found a link between individuals’ daily spiritual experiences and overall well-being, say researchers from Baylor University and Harvard University.
Drug Patent Watch
OCTOBER 3, 2020
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twelve patents…. The post New patent expiration for Astrazeneca Ab drug QTERN appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
OCTOBER 3, 2020
Analysis shows 26% decrease over past 10 years CHICAGO – Almost 20 years into the opioid epidemic, there finally is evidence of significant and continual decreases in the abuse of these risky pain medications, according to an analysis of national data being presented at the ANESTHESIOLOGY® 2020 annual meeting. The rate of prescription opioids fell […].
Drug Patent Watch
OCTOBER 3, 2020
BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…. The post Drug Patent Expirations for the Week of October 4, 2020 appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
OCTOBER 3, 2020
Second study shows minority children half as likely to have surgery as white children CHICAGO – When it comes to surgery, minority children lag far behind white children, according to two analyses of large national databases being presented at the ANESTHESIOLOGY® 2020 annual meeting. One found Black children are more than twice as likely as […].
BioTech 365
OCTOBER 3, 2020
Post hoc analysis of Phase 2 FILLY study shows 39% reduction in rate of progression from nascent GA, an earlier form of disease, to GA in patients treated with pegcetacoplan monthly vs.
Scienmag
OCTOBER 3, 2020
A nationwide analysis suggests that surgery may be safer and more effective than nonsurgical treatment of a ruptured or abscessed appendix during pregnancy CHICAGO: Pregnant women who underwent immediate surgery to treat a ruptured or abscessed appendix and their fetuses had significantly better outcomes than those whose condition was managed without an operation.
BioTech 365
OCTOBER 3, 2020
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
OCTOBER 3, 2020
Researchers used national database to study impact of language barriers in women of recommended screening age CHICAGO: Limited English-language proficiency (LEP) is a risk factor for getting potentially lifesaving screening mammograms less often, according to new study results using national data. These findings, from women aged 40 and older living in the United States, are […].
BioTech 365
OCTOBER 3, 2020
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated September 16, 2020 to its short form base shelf prospectus dated September 2, 2020. Not for Distribution to U.S.
Scienmag
OCTOBER 3, 2020
CHICAGO – Universal COVID-19 testing of children who are having procedures requiring anesthesia promotes efficient use of personal protective equipment (PPE), according to research being presented at the ANESTHESIOLOGY® 2020 annual meeting. Testing can rule out children who would otherwise be suspected of having COVID-19 based on symptoms or possible exposure to the virus.
BioTech 365
OCTOBER 3, 2020
DGAP-News: Siemens Healthineers AG / Key word(s): Share Buyback 03.10.2020 / 10:25 The issuer is solely responsible for the content of this announcement. Disclosure pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014 (MAR) and Art.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
OCTOBER 3, 2020
Beta test of American College of Surgeons Geriatric Surgery Verification Program in reveals reduced delirium, shorter hospital stays for aging veterans CHICAGO: People age 65 years and older account for 40 percent of inpatient operations and one-third of outpatient procedures,1,2 and these older patients are more vulnerable to longer hospital stays and other complications after […].
Drug Patent Watch
OCTOBER 3, 2020
This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Colombia? appeared first on DrugPatentWatch - Make Better Decisions.
Let's personalize your content